11 Facts About Yaakov Nahmias

Yaakov "Koby" Nahmias is an Israeli biomedical engineer and entrepreneur.

Yaakov Nahmias is the founding director of the Alexander Grass Center for Bioengineering.

Yaakov Nahmias is a co-founder of Israel's BioDesign Medical Innovation program, recently listed as a major reason for Boston Scientific's continued investment in Israel.

Yaakov Nahmias edited a book titled Microdevices in Biology and Medicine, and is currently serving as a technology consultant for L'Oreal, and a member of the European Research Council panel for applied life sciences and biotechnology.

In 2018, Yaakov Nahmias became the co-founder and chief scientific officer of Future Meat Technologies.

Yaakov Nahmias completed his PhD at the University of Minnesota with David Odde, and his postdoctoral training at Harvard Medical School with Martin Yarmush.

Yaakov Nahmias moved to the Hebrew University of Jerusalem in 2009, where he won two major European Research Council Starting and Consolidator Grants, and founded the Alexander Grass Center for Bioengineering.

In 2010, Yaakov Nahmias became a Golda Meir fellow and a member of the ERC Starting Grant panel on applied life sciences and biotechnology.

Yaakov Nahmias is a liver biologist and a biomedical engineer who took part in the development of Lodamin, the first oral, broad-spectrum angiogenesis inhibitor and the first decellularization of an intact liver for transplantation.

Yaakov Nahmias' work is leading to a growing understanding of the role of diet and nutrition on liver metabolism, including the first demonstration that gut bacteria affect liver development after birth, and explaining the toxic effects of acetaminophen using liver-on-chip technology.

Yaakov Nahmias is married to Michal Haimov, an attorney specializing in real estate and securities.